Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from hospitals in Lithuania

References

1. Arpin C., Quentin C., Grobost F., Cambau E., Robert J., Dubois V., Coulange L., Andre C. 2009; Nationwide survey of extended-spectrum β -lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 63:1205–1214 [CrossRef]
   [Google Scholar]
2. Boyd D. A., Tyler S., Christianson S., McGeer A., Muller M. P., Willey B. M., Bryce E., Gardam M., Nordmann P. other authors 2004; Complete nucleotide sequence of a 92-kilobase plasmid harbouring the CTX-M-15 extended-spectrum β -lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 48:3758–3764 [CrossRef]
   [Google Scholar]
3. Bradford P. A. 2001; Extended-spectrum β -lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951 [CrossRef]
   [Google Scholar]
4. Coque T. M., Baquero F., Canton R. 2008a; Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13:19044
   [Google Scholar]
5. Coque T. M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P. 2008b; Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β -lactamase CTX-M-15. Emerg Infect Dis 14:195–200 [CrossRef]
   [Google Scholar]
6. EARSS 2008 EARSS Annual Report 2007 Bilthoven: National Institute for Public Health and the Environment;
   [Google Scholar]
7. Eckert C., Gautier V., Arlet G. 2006; DNA sequence analysis of the genetic environment of various bla _CTX-M genes. J Antimicrob Chemother 57:14–23
   [Google Scholar]
8. Empel J., Baraniak A., Literacka E., Mrowka A., Fiett J., Sadowy E., Hryniewicz W., Gniadkowski M. 2008; Molecular survey of β -lactamases conferring resistance to newer β -lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 52:2449–2454 [CrossRef]
   [Google Scholar]
9. Fang H., Ataker F., Hedin G., Dornbush K. 2008; Molecular epidemiology of extended-spectrum β -lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 46:707–712 [CrossRef]
   [Google Scholar]
10. Lau S. H., Kaufmann M. E., Livermore D. M., Woodford N., Willshaw G. A., Cheasty T., Stamper K., Reddy S., Cheesbrough J. other authors 2008; UK epidemic Escherichia coli strains A-E, with CTX-M-15 β -lactamase, all belong to the international O25 : H4–ST131 clone. J Antimicrob Chemother 62:1241–1244 [CrossRef]
    [Google Scholar]
11. Livermore D. M., Canton R., Gniadkowski M., Nordmann P., Rossolini G. M., Arlet G., Ayala J., Coque T. M., Kern-Zdanowicz I. other authors 2007; CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59:165–174
    [Google Scholar]
12. Machado E., Coque T. M., Cantón R., Baquero F., Sousa J. C., Peixe L. Portuguese Resistance Study Group 2006; Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother 50:3220–3221 [CrossRef]
    [Google Scholar]
13. Munday C. J., Whitehead G. M., Todd N. J., Campbell M., Hawkey P. M. 2004; Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β -lactamases in York, UK. J Antimicrob Chemother 54:628–633 [CrossRef]
    [Google Scholar]
14. Park C. H., Robicsek A., Jacoby G. A., Sahm D., Hooper D. C. 2006; Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50:3953–3955 [CrossRef]
    [Google Scholar]
15. Perez-Perez F. J., Hanson N. D. 2002; Detection of plasmid-mediated AmpC β -lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153–2162 [CrossRef]
    [Google Scholar]
16. Vinue L., Saenz Y., Martinez S., Somalo S., Moreno M. A., Torres C., Zarazaga M. 2009; Prevalence and diversity of extended-spectrum β -lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 15:954–957 [CrossRef]
    [Google Scholar]
17. Yagi T., Kurokawa H., Shibata N., Shibayama K., Arakawa Y. 2000; A preliminary survey of extended-spectrum β -lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 184:53–56
    [Google Scholar]